MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

No. 83: Edwards Lifesciences

    Arrow  backEdwards Sapien 3

No. 83 Edwards Lifesciences 

Innovation Premium: 41.3%

Edwards Lifesciences continues to make great strides in the lucrative transcatheter aortic valve market. Just this month, Edwards's Sapien 3 valve became the first TAVR valve to receive an expanded FDA indication that included patients with intermediate risk of dying or suffering serious complications during open-heart surgery, versus the previous indication for only high risk patients. 

10 Medtech Startups on Fire in Q2 2016>>

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish